In particular, SMARCA4 is one of the most frequently aberrant chromatin remodeling ATPases in cancer, being altered in approximately 5–7% of all human malignancies; moreover, SMARCA4 genomic alterations and loss of SMARCA4 expression have been observed in some tumors [141]. This evidence concerns the gene SMARCA4 and cancer.